Medical condition
Influenza
Influenza is a medical condition tracked by NovaPharmaNews across 12 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- influenza mrna vaccine (MCOMBRIAX) Antiinfectives for systemic use (J07)
- peramivir (ALPIVAB) Antiinfectives for systemic use (J05)
- zanamivir (DECTOVA) Antiinfectives for systemic use (J05)
- baloxavir marboxil (XOFLUZA)
- zoonotic influenza vaccine (h5n8) (surface antigen, inactivated, adjuvanted) (ZOONOTIC INFLUENZA VACCINE SEQIRUS) Antiinfectives for systemic use (J07)
- zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) (CELLDEMIC) Antiinfectives for systemic use (J07)
- zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (AFLUNOV) Antiinfectives for systemic use (J07)
- trivalent influenza vaccine (recombinant, prepared in cell culture) (SUPEMTEK) Antiinfectives for systemic use (J07)
- quadrivalent influenza vaccine (recombinant, prepared in cell culture) (SUPEMTEK TETRA (PREVIOUSLY SUPEMTEK)) Antiinfectives for systemic use (J07)
- prepandemic influenza vaccine (h5n1) (whole virion, inactivated,prepared in cell culture) (VEPACEL) Antiinfectives for systemic use (J07)
- prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (PREPANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) NOVARTIS VACCINES AND DIAGNOSTICS) Antiinfectives for systemic use (J07)
- prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) (PREPANDRIX) Antiinfectives for systemic use (J07)